Companies: 10,795·Total market cap: $144.5T
HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

HTGMQOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$221
P/E Ratio
52W High$0.0001
52W Low$0.0001
Overview

HTG Molecular Diagnostics, Inc. (HTGMQ) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · HTGMQ · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-15.73htgmq eps ttm · htgmq earnings per shareEarnings history
PE Ratio (TTM)htgmq pe ratio ttm · htgmq price to earningsPE Ratio deep dive
Revenue (TTM)$6.2Mhtgmq revenue ttm · htgmq annual revenueFull revenue history
Dividend YieldNo Dividenddoes htgmq pay dividends · htgmq dividend yieldDividend history
Shares Outstanding889,284htgmq shares outstanding · htgmq floatShares outstanding history
Next EarningsAug 14, 2026Est.htgmq earnings date · htgmq next earningsEarnings history

Financial Snapshot

Full Financials
FY 2022Revenue$6.4M▼ 28.52% YoY
202020212022
htg molecular diagnostics, inc. revenue · htgmq revenue 2022
FY 2022Net Income-$21.6M▼ 25.95% YoY
202020212022
htg molecular diagnostics, inc. net income · htgmq profit 2022
FY 2022EPS$-24.28▲ +18.14% YoY
202020212022
htgmq eps · htg molecular diagnostics, inc. earnings per share 2022
TTM:Revenue: $6.2MNet Income: -$20.2MEPS: $-15.73View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis htgmq a buy · htgmq analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.00Current
$Avg Target
$High
htgmq price target · htgmq 12 month forecast

Total: 1 · Buy rate: 100.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+9900.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-100.00%

About HTG Molecular Diagnostics, Inc.

CEOJohn L. Lubniewski
IPO DateMay 6, 2015
Employees53
CountryUS

HTG Molecular Diagnostics, Inc. operates as a life sciences company, specializing in the realm of precision medicine. They furnish specialized instruments, consumable products, and software applicatio…

what is htg molecular diagnostics, inc. · htgmq stock overview · htg molecular diagnostics, inc. company profile · who is htg molecular diagnostics, inc. ceo · htgmq OTC · htg molecular diagnostics, inc. headquarters · htg molecular diagnostics, inc. business segments

About Stock Overview & Key Data

HTG Molecular Diagnostics, Inc. (HTGMQ) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since May 6, 2015. As of the latest trading session, HTGMQ stock price is $0.00, with a market capitalization of $221. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.

According to 1 Wall Street analysts, the consensus rating for HTG Molecular Diagnostics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, HTG Molecular Diagnostics, Inc. reported revenue of $6.4M and net income of -$21.6M. For detailed data — including HTG Molecular Diagnostics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, HTG Molecular Diagnostics, Inc. (HTGMQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol HTGMQ. The 52-week range is $0.00 – $0.00.

HTGMQ stock priceHTGMQ quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice